SCHEMBL8307747

SCHEMBL8307747

CC(=NOCCOC1CCCCO1)c1ccccc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4C Q9H3R0 1/20 0.39
ADORA3 P0DMS8 1/20 0.35
GAA P10253 1/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ITGB1 P05556 1/20 0.34
ITGA4 P13612 1/20 0.34
EP300 Q09472 1/20 0.34
CREBBP Q92793 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CHRNB2 P17787 2/20 0.33
CHRNB4 P30926 2/20 0.33
CHRNA3 P32297 2/20 0.33
CHRNA4 P43681 2/20 0.33
HCRTR1 O43613 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3083561 0.84 L3MBTL1 (0.47) MEN1KMT2AKDM4CLMNASMN1; SMN2
SCHEMBL3083559 0.84 L3MBTL1 (0.47) MEN1KMT2AKDM4CLMNASMN1; SMN2
SCHEMBL8308833 0.81 PPARG (0.48) MEN1KMT2AKDM4CADORA3NPC1
SCHEMBL8310012 0.79 KDM4C (0.43) MEN1KMT2AKDM4CADORA3NPC1
SCHEMBL8309642 0.79 KDM4C (0.42) MEN1KMT2AKDM4CADORA3GAA
SCHEMBL8309057 0.78 KDM4C (0.39) MEN1KMT2AKDM4CADORA3EP300
SCHEMBL3088344 0.76 KDM4C (0.48) MEN1KMT2AKDM4CALDH1A1LMNA
SCHEMBL3088343 0.76 KDM4C (0.48) MEN1KMT2AKDM4CALDH1A1LMNA
SCHEMBL8308456 0.74 KDM4C (0.44) MEN1KMT2AKDM4CGAAALDH1A1
SCHEMBL3071599 0.74 KMT2A (0.49) MEN1KMT2AKDM4CALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed